Nicole standing

About

Omnigence Asset Management is a $1B+ multi-strategy, alternative investment firm with its first fund launched 2007 and current evergreen funds active in farmland, lower market private equity and multi-asset.

We prefer novel and underinvested segments of the alternative universe. Less financialized market segments often exhibit higher returns, reliable alpha and better capital deployment prospects due to reduced competition, in addition to useful correlation benefits with reduced volatility when compared to more mainstream alternative asset classes.

Untapped
Alpha

We provide our investors with access to unique deal flow, strong operational value creation and strategies that provide proven portfolio enhancements.

Overlooked
Segments

We seek markets which are under-financialized and fragmented, that require deep networks to access and where assets are discounted with clear catalysts for mean reversion.

Strong
Alignment

Our management team has material capital committed to all the strategies, and we designed our funds with the clear intention of creating LP/GP alignment.

Value
Creation

Our proprietary platforms optimize execution and operations and allow real-time monitoring and adjustment across our portfolios, using technology ranging from satellites, AI and business intelligence driving 5,000+ KPIs and over 5B+ data records.

Description

Our team has been investing in alternatives since 2007 growing across a range of innovative and unique strategies.

2007

Canada’s first RRSP eligible farmland vehicle launched

2009

TerraFIRST farmland investment, operations, continuous improvement and monitoring platform launched

2013

Lower market private equity vehicle launched

2015

EquiONE private equity investment, operations, continuous improvement and monitoring platform launched

2019

Healthcare consolidation platform launched

2020

Sixth farmland fund exited

2021

14th operating business acquired

2022

Farmland vertical reach 100,000+ acres with AUM $93M

2023

Private equity vertical reaches $43M in gross EBITDA and ~1300 employees

2024

Dental laboratory consolidation completed and vertical taken to market

2025

Unconstrained, multi-strategy vehicle launched